glp-1 drug liraglutide may protect against dementia Prevention of with Medications: Benefits & Insights Ozempic predecessor suggests potential for
Description
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
Central nervous system effects include appetite suppression through actions on hypothalamic centers that regulate hunger and satiety
Several well-established and widely prescribed GLP-1 receptor agonists, including various formulations of semaglutide, liraglutide, and dulaglutide, are administered via subcutaneous injection
July 17, 2023
Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease
Large CVOTs and other smaller studies have shown an association between the use of GLP-1RAs and DPP-4i on the relative rates of HF hospitalization
